OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
Matthew G. Davey, Aoïfe Lowery, Nicola Miller, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10812-10812
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice
Laura López-González, Alicia Sánchez Cendra, Cristina Sánchez Cendra, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 168-168
Open Access | Times Cited: 15

Classic and New Markers in Diagnostics and Classification of Breast Cancer
Roman Beňačka, Daniela Szabóová, Zuzana Guľašová, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5444-5444
Open Access | Times Cited: 56

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
Fan Yang, Qingjie He, Xiangpeng Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27

MiRNAs as new potential biomarkers and therapeutic targets in brain metastasis
Ozal Beylerli, Huaizhang Shi, Sema Begliarzade, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 678-686
Open Access | Times Cited: 7

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
Vinitha Richard, Matthew G. Davey, Heidi Annuk, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5332-5332
Open Access | Times Cited: 28

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer
Matthew G. Davey, Maire Caitlin Casey, Andrew McGuire, et al.
Annals of Surgery (2022) Vol. 276, Iss. 5, pp. 905-912
Open Access | Times Cited: 22

MicroRNAs as biomarkers in brain metastasis
Farag M. A. Altalbawy, Ahmed Hussein Zwamel, Gaurav Sanghvi, et al.
Clinica Chimica Acta (2025), pp. 120292-120292
Closed Access

The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer
Vinitha Richard, Matthew G. Davey, Heidi Annuk, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 18

Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review
Luis Bouz Mkabaah, Matthew G. Davey, James C. Lennon, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7115-7115
Open Access | Times Cited: 10

Sentinel lymph node biopsy in patients with ductal carcinomain situ: systematic review and meta-analysis
Matthew G. Davey, Colm O’Flaherty, Eoin F. Cleere, et al.
BJS Open (2022) Vol. 6, Iss. 2
Open Access | Times Cited: 14

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
Matthew G. Davey, Gerard Feeney, Heidi Annuk, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2109-2109
Open Access | Times Cited: 14

miR-21, miR-29a, and miR-106b: serum and tissue biomarkers with diagnostic potential in metastatic testicular cancer
Zsuzsanna Újfaludi, Fruzsina Fazekas, Krisztina Bíró, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment
Molly Davies, Matthew G. Davey, Nicola Miller
Genes (2022) Vol. 13, Iss. 11, pp. 2054-2054
Open Access | Times Cited: 12

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
Matthew G. Davey, Andrew McGuire, Máire‐Caitlín Casey, et al.
Journal of the American College of Surgeons (2022) Vol. 236, Iss. 2, pp. 317-327
Open Access | Times Cited: 12

An Epigenetic LINE-1-Based Mechanism in Cancer
Patrizia Lavia, Ilaria Sciamanna, Corrado Spadafora
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14610-14610
Open Access | Times Cited: 11

Revisiting the hallmarks of cancer: A new look at long noncoding RNAs in breast cancer
Pablo Igor Ribeiro Franco, José Rodrigues do Carmo Neto, Liliana Borges de Menezes, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154381-154381
Closed Access | Times Cited: 6

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
Matthew G. Davey, Ray Abbas, Eoin Kerin, et al.
Breast Cancer Research and Treatment (2023) Vol. 202, Iss. 1, pp. 73-81
Open Access | Times Cited: 6

Targeting the ZNF‐148/miR‐335/SOD2 signaling cascade triggers oxidative stress‐mediated pyroptosis and suppresses breast cancer progression
Yanmei Wang, Yansi Gong, Xuesha Li, et al.
Cancer Medicine (2023) Vol. 12, Iss. 23, pp. 21308-21320
Open Access | Times Cited: 6

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis
Matthew G. Davey, Eoin F. Cleere, John P. O’Donnell, et al.
Breast Cancer Research and Treatment (2022) Vol. 193, Iss. 3, pp. 535-544
Open Access | Times Cited: 9

Unravelling the roles of Autophagy in OSCC: A renewed perspective from mechanisms to potential applications
Qiutong Gou, Lingli Zheng, Haixia Huang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9

The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis
Antonis Tsintarakis, Chara Papalouka, Christina Kontarini, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1361-1361
Open Access | Times Cited: 5

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
Matthew G. Davey, Martin S. Davey, Vinitha Richard, et al.
Breast Cancer Basic and Clinical Research (2022) Vol. 16
Open Access | Times Cited: 8

Shenqi Fuzheng Injection Reduces Cisplatin-Induced Kidney Injury via cGAS/STING Signaling Pathway in Breast Cancer Mice Model
Yingrui Ma, Bufan Bai, Liu Deng, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 451-469
Open Access | Times Cited: 1

siRNA-based therapy for overcoming drug resistance in human solid tumours; molecular and immunological approaches
Harikumar Pallathadka, Majid S. Jabir, Khetam H. Rasool, et al.
Human Immunology (2024) Vol. 86, Iss. 1, pp. 111221-111221
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top